Topics

Novartis Eyes New Cosentyx Approval After Positive Axial Spondyloarthritis Trial

20:00 EDT 2 Oct 2019 | BioSpace

In a Phase III trial, Cosentyx showed a significant and clinically meaningful reduction in disease activity for patients versus placebo.

Original Article: Novartis Eyes New Cosentyx Approval After Positive Axial Spondyloarthritis Trial

NEXT ARTICLE

More From BioPortfolio on "Novartis Eyes New Cosentyx Approval After Positive Axial Spondyloarthritis Trial"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...